SES To Test Broadcast Real Madrid vs. Barcelona Football Match in Ultra High Definition
SES S.A. (NYSE Paris:SESG) (LuxX:SESG) announced today that it will test broadcast Saturday’s Real Madrid vs. Barcelona football match in Ultra High Definition (Ultra HD) via SES’s ASTRA 1L satellite at 19.2 degrees East. The transmission is part of the Ultra HD technical tests being conducted by SES, Movistar+ and other industry partners.
“A test live broadcast of a football match in Ultra High Definition marks another milestone in the introduction of this new technology in Spain, as well as in Europe, and shows the readiness of the Ultra HD ecosystem,” said Luis Sahún, General Manager of Spain at SES. “Thanks to satellite and its ability to cost-effectively deliver the best quality content to a large audience, it is only a matter of time before the live broadcast of Ultra HD content becomes part of our daily TV viewing experience.”
Follow us on:
SES Pictures are available under http://www.ses.com/4245221/library
SES (NYSE Paris:SESG) (LuxX:SESG) is the world-leading satellite operator with a fleet of more than 50 geostationary satellites. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators and business and governmental organisations worldwide.
SES stands for long-lasting business relationships, high-quality service and excellence in the satellite industry. The culturally diverse regional teams of SES are located around the globe and work closely with customers to meet their specific satellite bandwidth and service requirements.
SES holds a participation in O3b Networks, a next generation satellite network combining the reach of satellite with the speed of fibre. Further information available at: www.ses.com .
For further information please contact:
Tel. +352 710 725 500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SHELL/BIO-BEAN20.11.2017 01:03 | pressemeddelelse
Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses
SAMSUNG-BIOEPIS19.11.2017 23:23 | pressemeddelelse
Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®
FOCP19.11.2017 17:33 | pressemeddelelse
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life
ASTRAZENECA19.11.2017 00:02 | pressemeddelelse
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases
ASTRAZENECA18.11.2017 19:22 | pressemeddelelse
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer
CHINA-HI-TECH-FAIR18.11.2017 10:13 | pressemeddelelse
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum